09.01.09
Sabinsa Corporation, Piscataway, NJ, has obtained GRAS (Generally Recognized As Safe) status for its branded and patented antioxidant ingredient Curcumin C3 Complex following a comprehensive review of safety and toxicology data by an independent panel of scientists. Self-affirmed GRAS status allows manufacturers to add Curcumin C3 Complex in a variety of foods and beverages. In other developments, Sabinsa has received approval from the Korean FDA for its ForsLean ingredient following submission of a dossier that included safety and toxicological data. The approval allows Sabinsa’s partner, Cheil Jedang Corporation to promote ForsLean in the Korean market with a specific health claim: “reduces body fat” with a recommended dosage of 500 mg.